Visara appoints ophthalmology leaders to advance VIS-101 drug program
Go back to Visara appoints ophthalmology leaders to advance VIS-101 drug program| (NASDAQ: AURA) | Delayed: 7.02 +0.07 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.95 | 52 Week High | $ | |||
| Open | $6.81 | 52 Week Low | $ | |||
| Day High | $7.28 | P/E | N/A | |||
| Day Low | $6.55 | EPS | $ | |||
| Volume | 500,366 | |||||
| (NASDAQ: FDMT) | Delayed: 11.60 +1.18 (11.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.42 | 52 Week High | $ | |||
| Open | $10.22 | 52 Week Low | $ | |||
| Day High | $12.18 | P/E | N/A | |||
| Day Low | $10.22 | EPS | $ | |||
| Volume | 2,068,949 | |||||
| (NASDAQ: NBP) | Delayed: 1.61 +0.08 (5.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.53 | 52 Week High | $6.95 | |||
| Open | $1.50 | 52 Week Low | $6.95 | |||
| Day High | $1.65 | P/E | 0.75 | |||
| Day Low | $1.47 | EPS | $2.14 | |||
| Volume | 424,159 | |||||

